These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 10980055

  • 21. Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD).
    Zimmermann T, Hoppe-Lotichius M, Tripkovic V, Barreiros AP, Wehler TC, Zimmermann A, Schattenberg JM, Heise M, Biesterfeld S, Galle PR, Otto G, Schuchmann M.
    Eur J Intern Med; 2010 Jun; 21(3):208-15. PubMed ID: 20493424
    [Abstract] [Full Text] [Related]

  • 22. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 23. Hepatitis C is a risk factor for death after liver retransplantation.
    Pelletier SJ, Schaubel DE, Punch JD, Wolfe RA, Port FK, Merion RM.
    Liver Transpl; 2005 Apr; 11(4):434-40. PubMed ID: 15776460
    [Abstract] [Full Text] [Related]

  • 24. Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome.
    Ben-Ari Z, Amlot P, Lachmanan SR, Tur-Kaspa R, Rolles K, Burroughs AK.
    Liver Transpl Surg; 1999 May; 5(3):184-91. PubMed ID: 10226108
    [Abstract] [Full Text] [Related]

  • 25. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.
    Newell KA, Alonso EM, Whitington PF, Bruce DS, Millis JM, Piper JB, Woodle ES, Kelly SM, Koeppen H, Hart J, Rubin CM, Thistlethwaite JR.
    Transplantation; 1996 Aug 15; 62(3):370-5. PubMed ID: 8779685
    [Abstract] [Full Text] [Related]

  • 26. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
    Glez-Chamorro A, Jimenez C, Moreno-Glez E, Glez-Pinto I, Loinaz C, Gomez R, Garcia I, Alonso O, Palma F, Grande C.
    Hepatogastroenterology; 2000 Aug 15; 47(31):211-9. PubMed ID: 10690611
    [Abstract] [Full Text] [Related]

  • 27. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
    Mendoza F, Kunitake H, Laks H, Odim J.
    Pediatr Transplant; 2006 Feb 15; 10(1):60-6. PubMed ID: 16499589
    [Abstract] [Full Text] [Related]

  • 28. Adult post-transplant lymphoproliferative disease in the liver graft in patients with recurrent hepatitis C.
    Kim RD, Fujikawa T, Mizuno S, Schwartz JJ, Sorensen JB, Hemming AW, Fujita S.
    Eur J Gastroenterol Hepatol; 2011 Jul 15; 23(7):559-65. PubMed ID: 21555941
    [Abstract] [Full Text] [Related]

  • 29. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
    Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW.
    J Clin Oncol; 2009 Jul 10; 27(20):3354-62. PubMed ID: 19451438
    [Abstract] [Full Text] [Related]

  • 30. Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience.
    Mendizabal M, Marciano S, dos Santos Schraiber L, Zapata R, Quiros R, Zanotelli ML, Rivas MM, Kusminsky G, Humeres R, Alves de Mattos A, Gadano A, Silva MO.
    Clin Transplant; 2013 Jul 10; 27(4):E469-77. PubMed ID: 23758407
    [Abstract] [Full Text] [Related]

  • 31. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
    Burra P, Buda A, Livi U, Rigotti P, Zanus G, Calabrese F, Caforio A, Menin C, Canova D, Farinati F, Luciana Aversa SM.
    Eur J Gastroenterol Hepatol; 2006 Oct 10; 18(10):1065-70. PubMed ID: 16957512
    [Abstract] [Full Text] [Related]

  • 32. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
    Aguilera V, Berenguer M, Rubín A, San-Juan F, Rayón JM, Prieto M, Mir J.
    Liver Transpl; 2009 Jan 10; 15(1):79-87. PubMed ID: 19109849
    [Abstract] [Full Text] [Related]

  • 33. Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients.
    Shahinian VB, Muirhead N, Jevnikar AM, Leckie SH, Khakhar AK, Luke PP, Rizkalla KS, Hollomby DJ, House AA.
    Transplantation; 2003 Mar 27; 75(6):851-6. PubMed ID: 12660514
    [Abstract] [Full Text] [Related]

  • 34. Comparison of hepatitis C histological recurrence rates and patient survival between split and deceased donor liver transplantation.
    Lawal A, Ghobrial R, Te H, Artinian L, Eastwood D, Schiano TD.
    Transplant Proc; 2007 Dec 27; 39(10):3261-5. PubMed ID: 18089367
    [Abstract] [Full Text] [Related]

  • 35. Impact of hepatitis C virus infection on patient and graft survival in kidney transplantation.
    Manga Sahin G, Sahin S, Kantarci G, Ergin H.
    Transplant Proc; 2006 Mar 27; 38(2):499-501. PubMed ID: 16549159
    [Abstract] [Full Text] [Related]

  • 36. Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients.
    Tector AJ, Fridell JA, Mangus RS, Shah A, Milgrom M, Kwo P, Chalasani N, Yoo H, Rouch D, Liangpunsakul S, Herring S, Lumeng L.
    Liver Transpl; 2004 Mar 27; 10(3):404-7. PubMed ID: 15004768
    [Abstract] [Full Text] [Related]

  • 37. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection : an observational multicenter study.
    Saliba F, Lakehal M, Pageaux GP, Roche B, Vanlemmens C, Duvoux C, Dumortier J, Salamé E, Calmus Y, Maugendre D, Diapason Study Group.
    Liver Transpl; 2007 Jan 27; 13(1):136-44. PubMed ID: 17192854
    [Abstract] [Full Text] [Related]

  • 38. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up.
    Neumann UP, Berg T, Bahra M, Puhl G, Guckelberger O, Langrehr JM, Neuhaus P.
    Transplantation; 2004 Jan 27; 77(2):226-31. PubMed ID: 14742986
    [Abstract] [Full Text] [Related]

  • 39. Posttransplant lymphoproliferative disorder.
    Everly MJ, Bloom RD, Tsai DE, Trofe J.
    Ann Pharmacother; 2007 Nov 27; 41(11):1850-8. PubMed ID: 17940127
    [Abstract] [Full Text] [Related]

  • 40. Early posttransplant lymphoproliferative disease in pediatric liver transplant recipients.
    Roque J, Rios G, Humeres R, Volpi C, Herrera JM, Schultz M, Rios H, Rius M, Salgado C, Hepp J.
    Transplant Proc; 2006 Apr 27; 38(3):930-1. PubMed ID: 16647513
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.